切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2013, Vol. 02 ›› Issue (06) : 288 -291. doi: 10.3877/cma.j.issn.2095-3224.2013.06.02

所属专题: 文献

专家论坛

中国结直肠癌防治现状
邢洁1, 李鹏1, 张澍田1,()   
  1. 1. 100050 北京,首都医科大学附属北京友谊医院
  • 收稿日期:2013-11-05 出版日期:2013-12-25
  • 通信作者: 张澍田

The situations and problems of colorectal cancer treatment in China

Jie XING1, Peng LI1, Shu-tian ZHANG1,()   

  1. 1. Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
  • Received:2013-11-05 Published:2013-12-25
  • Corresponding author: Shu-tian ZHANG
  • About author:
    Corresponding author: ZHANG Shu-tian, Email:
引用本文:

邢洁, 李鹏, 张澍田. 中国结直肠癌防治现状[J]. 中华结直肠疾病电子杂志, 2013, 02(06): 288-291.

Jie XING, Peng LI, Shu-tian ZHANG. The situations and problems of colorectal cancer treatment in China[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2013, 02(06): 288-291.

结直肠癌在我国发病率逐年增高,已接近发达国家水平。早期筛查和治疗及后期的随访对于降低结直肠癌发病率及死亡率至关重要。笔者对我国的结直肠癌临床防治中取得的成果及面临的问题进行了系统的阐述。

The colorectal caner related morbidity in China is increasing gradually approaching the levels of developed countries in recent years.The early screening and treatment, as well as the follow-ups, are significant in reducing the morbidity and mortality related with colorectal caner.In this article, the general situations and problems in these fields are systematically expounded.

[1]
Ferlay J,Shin H R,Bray F,et al.GLOBOCAN 2008,cancer incidence and mortality worldwide:IARC CancerBase No.10.Lyon,France:International Agency for Research on Cancer,2010,2010:29.
[2]
汪建平.重视结直肠癌流行病学研究.中国实用外科杂志,2013,33(8):622-624.
[3]
Jimenez CR,Knol JC,Meijer GA,et al.Proteomics of colorectal cancer:overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.Journal of proteomics,2010,73(10):1873-1895.
[4]
Johnson CM,Wei C,Ensor JE,et al.Meta-analyses of colorectal cancer risk factors.Cancer Causes & Control,2013,24(6):1207-1222.
[5]
Stegeman I,Wijkerslooth TR,Stoop EM,et al.Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer.Cancer epidemiology,2013,37(3):278-283.
[6]
Nolfo F,Rametta S,Marventano S,et al.Pharmacological and dietary prevention for colorectal cancer.BMC surgery,2013,13:S16.
[7]
Chen HM,Weng YR,Jiang B,et al.Epidemiological study of colorectal adenoma and cancer in symptomatic patients in China between 1990 and 2009.Journal of digestive diseases,2011,12(5):371-378.
[8]
Rundle A G,Lebwohl B,Vogel R,et al.Colonoscopic screening in average-risk individuals ages 40 to 49 vs 50 to 59 years.Gastroenterology,2008,134(5):1311-1315.
[9]
Edwards BK,Ward E,Kohler BA,et al.Annual report to the nation on the status of cancer,1975-2006,featuring colorectal cancer trends and impact of interventions(risk factors,screening,and treatment) to reduce future rates.Cancer,2010,116(3):544-573.
[10]
董志伟,乔友林.中国癌症早诊早治的实践与思考.中国肿瘤,2009,18(9):686-689.
[11]
Levin B,Lieberman DA,McFarland B,et al.Screening and Surveillance for the early detection of colorectal cancer and adenomatous polyps,2008:a Joint guideline from the american cancer Society,the US multi‐society task force on colorectal cancer,and the american college of radiology**.CA:a cancer journal for clinicians,2008,58(3):130-160.
[12]
Sung JJY,Lau JYW,Young GP,et al.Asia pacific consensus recommendations for colorectal cancer screening.Gut,2008,57(8):1166-1176.
[13]
房静远.中国结直肠肿瘤筛查,早诊早治和综合预防共识意见(一).中华消化杂志,2012,32(001):1-10.
[14]
姜泊,刘思德.中国早期大肠癌内镜诊治共识意见.中华消化内镜杂志,2008,25(12):321-324.
[15]
Tanaka S,Oka S,Kaneko I,et al.Endoscopic submucosal dissection for colorectal neoplasia:possibility of standardization.Gastrointestinal endoscopy,2007,66(1):100-107.
[16]
Hotta K,Yamaguchi Y,Saito Y,et al.Current opinions for endoscopic submucosal dissection for colorectal tumors from our experiences:indications,technical aspects and complications.Digestive Endoscopy,2012,24:110-116.
[17]
Takeuchi Y,Ohta T,Matsui F,et al.Indication,strategy and outcomes of endoscopic submucosal dissection for colorectal neoplasm.Digestive Endoscopy,2012,24:100-104.
[18]
姚礼庆,时强.早期结直肠癌及癌前病变内镜治疗和评价.中国实用外科杂志,2012,32(9):734-738.
[19]
Edwards BK,Ward E,Kohler BA,et al.Annual report to the nation on the status of cancer,1975-2006,featuring colorectal cancer trends and impact of interventions(risk factors,screening,and treatment) to reduce future rates.Cancer,2010,116(3):544-573.
[20]
Centers for disease control and prevention(CDC.Vital signs:colorectal cancer screening,incidence,and mortality-United States,2002-2010.MMWR.Morbidity and mortality weekly report,2011,60(26):884.
[21]
谢莉萍,彭慧,黄南祺,等.结直肠癌及其筛查认知情况,筛查意愿与文化程度相关性的调查分析.中华普通外科学文献(电子版),2013,7(3):57-60.
[22]
Salimzadeh H,Delavari A,Montazeri A,et al.Knowledge and practice of iranians toward colorectal cancer,and barriers to screening.International journal of preventive medicine,2012,3(1):29.
[23]
Cavanagh MF,Lane DS,Messina CR,et al.Clinical case management and navigation for colonoscopy screening in an academic medical center.Cancer,2013,119(S15):2894-2904.
[24]
Tanaka S,Terasaki M,Kanao H,et al.Current status and future perspectives of endoscopic submucosal dissection for colorectal tumors.Digestive Endoscopy,2012,24(s1):73-79.
[1] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[2] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[3] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[4] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[5] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[6] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[7] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[8] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[9] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[10] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[11] 黄怡诚, 陆晨, 孙司正, 喻春钊. 肝特异性转录因子FOXA2在人结直肠癌肝转移阶梯模型中的表达变化及其意义[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 396-403.
[12] 刘祺, 张凯, 李建男, 刘铜军. 结直肠癌肝转移生物治疗的现状及进展[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 415-419.
[13] 吴寅, 陈智琴, 高勇, 权明. Her-2阳性结直肠癌的诊治进展[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 420-425.
[14] 范博洋, 王宁, 张骞, 王贵玉. 结直肠癌转移调控的环状RNA分子机制研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 426-430.
[15] 孙昕, 程海波, 沈卫星. 基于全转录组学探讨仙连解毒方治疗Ⅲ期结直肠癌患者的疗效机制[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 277-283.
阅读次数
全文


摘要